Palvella Therapeutics Inc (PVLA)
27.30 -0.46 (-1.66%) 16:08 ET [NASDAQ]
27.78 x 100 28.10 x 700
Realtime by (Cboe BZX)
27.78 x 100 28.10 x 700
Realtime - - (-) -
for Fri, Mar 28th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
Sales | 0 | 0 | 53 | 1,299 | 19,520 |
Gross Profit | N/A | N/A | 53 | 1,299 | 19,520 |
Operating Expenses | 3,135 | 4,177 | 5,356 | 5,800 | 31,327 |
Operating Income | -3,135 | -4,177 | -5,303 | -4,501 | -11,807 |
Other Income | 248 | 587 | 411 | -83 | 1,055 |
Pre-tax Income | -2,887 | -3,590 | -4,892 | -4,584 | -10,752 |
Net Income Continuous | -2,887 | -3,590 | -4,892 | -4,584 | -10,752 |
Net Income | $-2,887 | $-3,590 | $-4,892 | $-4,584 | $-10,752 |
EPS Basic Total Ops | -2.19 | -2.76 | -3.95 | -2.38 | -8.70 |
EPS Basic Continuous Ops | -2.19 | -2.76 | -3.95 | -2.57 | -8.70 |
EPS Diluted Total Ops | -2.19 | -2.76 | -3.95 | -2.37 | -8.70 |
EPS Diluted Continuous Ops | -2.19 | -2.76 | -3.95 | -2.56 | -8.70 |
EPS Diluted Before Non-Recurring Items | -2.19 | -2.76 | -3.95 | -4.00 | -8.80 |
EBITDA(a) | $-3,135 | $-4,177 | $-5,333 | $-4,699 | $-11,068 |